Lakefront Biotherapeutics (LKFT) Investment Income (2017 - 2018)
Lakefront Biotherapeutics (LKFT) reported Investment Income of $17.3 million for Q3 2018, up 140.13% year-over-year from $7.2 million in Q3 2017, and up 140.13% quarter-over-quarter from -$43.0 million in Q3 2017.
Lakefront Biotherapeutics (LKFT) Investment Income (2017 - 2018) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 2 years of Investment Income data on file, last reported at $17.3 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 17.26 Mn |
| Sep 30, 2017 | -43.02 Mn |